Insite Vision Inc (INSV) Gross Profit Margin starting from the second quarter 2015 to second quarter 2014, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Insite Vision Inc  (INSV)


Insite Vision Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INSV Gross Profit Margin (Jun 30 2015)
Q2 		(Mar 31 2015)
Q1 		(Dec 31 2014)
Q4 		(Sep 30 2014)
Q3 		(Jun 30 2014)
Q2
Y / Y Revenue Change -93.83 %
Seq. Revenue Change -88.39 %
Revenue In Millions $0.39
Gross Profit Margin 63.01 %
Gross Profit Margin Total Ranking # 1422
Gross Profit In Millions $0.25
Y / Y Gross Profit Change -96.01 %
Seq. Gross Profit Change -92.39 %


Commenting Second Quarter 2015 Gross Profit Margin
Insite Vision Inc experienced contraction in Gross Profit by -92.39 % to $0 millions and Revenue by -88.39 %, while Gross Profit Margin fell to 63.01 %, below company*s average Gross Profit Margin.


Observing second quarter 2015 results within Major Pharmaceutical Preparations industry 67 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 133 to 1422.
Learn about Gross Margin
INSV's Gross Profit Margin second quarter 2015 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 68
Healthcare Sector # 180
Overall # 1151

Gross Profit Margin Statistics
High Average Low
99.72 % 86.83 % 56.11 %
(Dec 31 2013)   (Sep 30 2014)


INSV Gross Income Trends • More of INSV's Profitabilty Ratios • INSV Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
INSV's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
INSV's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for INSV's Competitors
Gross Profit Margin Profit Margin for Insite Vision Inc's Suppliers
Gross Profit Margin Profit Margin for INSV's Customers

You may also want to know
INSV's Annual Growth Rates INSV's Profitability Ratios INSV's Asset Turnover Ratio INSV's Dividend Growth
INSV's Roe INSV's Valuation Ratios INSV's Financial Strength Ratios INSV's Gross Profit Growth
INSV's Roa INSV's Inventory Turnover Ratio INSV's Growth Rates INSV's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2015, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2015 MRQ Gross ProfitJun 30 2015 MRQ Revenue
Allergan plc  99.90 %$ 3,624.900  Millions$ 3,628.700  Millions
Sangui Biotech International Inc  99.61 %$ 0.011  Millions$ 0.011  Millions
Immune Design Corp.  97.53 %$ 1.736  Millions$ 1.780  Millions
Travere Therapeutics Inc   97.35 %$ 23.431  Millions$ 24.068  Millions
Intelgenx Technologies Corp   96.75 %$ 0.566  Millions$ 0.585  Millions
Wellness Center Usa Inc  96.58 %$ 0.120  Millions$ 0.125  Millions
Corcept Therapeutics Inc  96.33 %$ 11.517  Millions$ 11.956  Millions
Celgene Corp  95.57 %$ 2,177.000  Millions$ 2,277.800  Millions
United Therapeutics Corporation  95.37 %$ 331.103  Millions$ 347.161  Millions
Kythera Biopharmaceuticals Inc  95.14 %$ 0.274  Millions$ 0.288  Millions
Regeneron Pharmaceuticals Inc   93.91 %$ 937.762  Millions$ 998.617  Millions
Alimera Sciences Inc  93.49 %$ 5.400  Millions$ 5.776  Millions
Supernus Pharmaceuticals inc   93.31 %$ 33.290  Millions$ 35.678  Millions
Theravance Biopharma inc   92.92 %$ 6.629  Millions$ 7.134  Millions
Alexion Pharmaceuticals Inc   91.83 %$ 584.203  Millions$ 636.210  Millions
Progenics Pharmaceuticals Inc  90.81 %$ 1.759  Millions$ 1.937  Millions
Vertex Pharmaceuticals Inc  89.85 %$ 149.216  Millions$ 166.076  Millions
Omeros Corporation  88.55 %$ 2.822  Millions$ 3.187  Millions
Insys Therapeutics, Inc.  86.44 %$ 69.328  Millions$ 80.200  Millions
Acura Pharmaceuticals inc  86.22 %$ 0.294  Millions$ 0.341  Millions
Sellas Life Sciences Group Inc   86.16 %$ 2.914  Millions$ 3.382  Millions
Cumberland Pharmaceuticals Inc   86.12 %$ 7.673  Millions$ 8.910  Millions
Ligand Pharmaceuticals Incorporated  85.88 %$ 15.818  Millions$ 18.418  Millions
Arena Pharmaceuticals Inc   85.81 %$ 7.878  Millions$ 9.181  Millions
Spectrum Pharmaceuticals Inc   84.62 %$ 38.066  Millions$ 44.982  Millions
Amag Pharmaceuticals inc   84.11 %$ 104.205  Millions$ 123.884  Millions
Biomarin Pharmaceutical Inc  84.08 %$ 210.645  Millions$ 250.523  Millions
Ani Pharmaceuticals Inc  83.91 %$ 16.375  Millions$ 19.516  Millions
Lifevantage Corp  83.90 %$ 38.008  Millions$ 45.301  Millions
Cti Biopharma Corp   83.36 %$ 0.917  Millions$ 1.100  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.